[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kirkpatrick, 2002 - Google Patents

Antibacterial Drugs: Stitching together naturally.

Kirkpatrick, 2002

Document ID
7245783850731364620
Author
Kirkpatrick P
Publication year
Publication venue
Nature Reviews Drug Discovery

External Links

Snippet

Cites the study'Biomimetic synthesis and optimization of cyclic peptide antibiotics,'by RM Kohlil et al, published in a 2002 issue of'Nature.'Use of an isolated bacterial enzyme in combination with conventional solid-phase peptide synthesis to produce compounds related …
Continue reading at search.ebscohost.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Similar Documents

Publication Publication Date Title
Kirkpatrick Antibacterial Drugs: Stitching together naturally.
US5756466A (en) Inhibitors of interleukin-1β converting enzyme
US6274336B1 (en) Method of inhibiting cathepsin K
Ziarek et al. Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery
CN101490557B (en) Methods for the identification of ZAP-70 interacting molecules and for the purification of ZAP-70
US9023876B2 (en) Compounds and methods for regulating integrins
Guillory et al. Fragment-based differential targeting of PPI stabilizer interfaces
JP6198807B2 (en) Engineered and conformationally stabilized protein
EA018050B1 (en) Kallikrein 7 modulators, pharmaceutical composition comprising said compounds, method of treating disorders mediated by kallikrein 7 activity
Zhang et al. Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids
Sarkar et al. Inhibiting Matrix Metalloproteinase-2 Activation by Perturbing Protein–Protein Interactions Using a Cyclic Peptide
Erickson et al. Macromolecular X-ray crystallography and NMR as tools for structure-based drug design
Takeuchi et al. Discovery of aryloxyphenyl–heptapeptide hybrids as potent and selective matrix metalloproteinase-2 inhibitors for the treatment of idiopathic pulmonary fibrosis
Dorman et al. Discovery of non-peptide small molecule allosteric modulators of the Src-family kinase, Hck
Herkommer et al. Design, synthesis, and biological evaluation of simplified side chain hybrids of the potent actin binding polyketides rhizopodin and bistramide
Brazil Therapeutic Proteins: High affinity good, lower affinity better.
Brazil G-Protein-Coupled Receptors: Lipidated peptides: a therapeutic tool kit.
Frantz Ligands: Sorting good from bad.
ADVISORS et al. for gold
Kirkpatrick Computational Chemistry: Panning for gold.
US10293024B2 (en) MAP kinase P38 binding compounds
Qvit et al. Peptides that target protein-protein interactions as an anti-parasite strategy
WO1997008300A9 (en) Crystalline zap family proteins
JPH11510061A (en) Crystalline ZAP family proteins
Weiner et al. Biological approaches to rational drug design